AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Magnifying glass

Making payers’ prior authorization data easier to access, understand

| 4 Min Read
Patient smiles at healthcare worker

Building a strong primary care physician workforce

| 7 Min Read
Row of figures with one called out by an exclamation point

Physician-lawyer on private practice HR: Here’s how to hire—and fire

| 5 Min Read
Mohamad Mokadem, MD, featured on "Health vs. Hype" AMA podcast

9 things that patients should know about gut health

| 5 Min Read